MD and PhD Student Esben Carlsen presenting the results of our phase II trial on integrin αvβ3 imaging by 68Ga-NODAGA-E[c(RGDyK)]2 in patients with neuroendocrine neoplasms at SNMMI 2022. The abstract was awarded 2nd place by the Early Career Professionals Committee (clinical).
Yesterday, Prof. Andreas Kjaer shared his vision of uPAR as a next generation theranostic target in cancers with a packed audience at the SNMMI Annual Meeting in Vancouver.
@kjaer_andreas
We are proud to share an Editorial by Tarkin and Goncalves in Atherosclerosis covering our recent publication on uPAR-PET with 64Cu-DOTA-AE105 for imaging of the development of atherosclerosis.
https://t.co/J8tPukL7uY